Literature DB >> 10567883

Role of urologic evaluation in the adult spina bifida patient.

M L Persun1, P C Ginsberg, J D Harmon, R C Harkaway.   

Abstract

OBJECTIVE: To evaluate a population of adult spina bifida patients performing clean intermittent catheterization (CIC) and determine the indications for urologic consultation and intervention.
METHODS: We evaluated 52 adults (ages 18-37 years) with a history of lumbar myelomeningocele, all of whom performed CIC and were dry between catheterizations. We excluded 12 patients with conditions potentially predisposing to renal insufficiency (staghorn calculus, n = 3; multiple admissions for pyelonephritis, n = 5; history of vesicoureteral reflux, n = 2, and renal scarring on ultrasound, n = 2), leaving 40 patients evaluable. Each patient kept a catheterization diary for 2 weeks from which an average catheterized volume was recorded.
RESULTS: In patients with normal ultrasound and normal serum creatinine (<1.5 mg/dl), there were no individuals (0/20) whose average catheterized volume corresponded to a bladder pressure of >40 cm H(2)O on cystometry. However, in the patients with hydronephrosis and/or elevated creatinine, 30% (6/20) had average catheterized volumes corresponding to a bladder pressure of >40 cm H(2)O, and are therefore theoretically at risk for upper tract deterioration.
CONCLUSION: Many spina bifida patients receive urologic care only as children, and those without urinary calculi or urinary incontinence are assumed to be urologically stable. However, certain patients have urodynamic parameters which put them at risk for renal deterioration even if they appear to be problem-free. We recommend a yearly renal ultrasound and serum creatinine determination in all adult spina bifida patients with immediate urologic consultation and urodynamics if either is abnormal. Copyright 1999 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567883     DOI: 10.1159/000030396

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  4 in total

Review 1.  Spina bifida.

Authors:  Alvaro A Saavedra; Dawn Maclellan; Gary J Gray
Journal:  Can Urol Assoc J       Date:  2018-04       Impact factor: 1.862

2.  Complications following breast cancer therapy in the adult spina bifida population: A case report.

Authors:  Nathan Y Hoy; Peter Metcalfe
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

3.  The spectrum of urological disease in patients with spina bifida.

Authors:  R A Cahill; E A Kiely
Journal:  Ir J Med Sci       Date:  2003 Oct-Dec       Impact factor: 1.568

Review 4.  Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review.

Authors:  Paul W Veenboer; J L H Ruud Bosch; Floris W A van Asbeck; Laetitia M O de Kort
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.